{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:24:15Z","timestamp":1772893455503,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272833"],"award-info":[{"award-number":["81272833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118514","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:04:56Z","timestamp":1756292696000},"page":"118514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["JS-K enhances renal cell carcinoma radiosensitivity through the Wnt\/\u03b2-catenin signaling pathway and inhibits DNA damage repair"],"prefix":"10.1016","volume":"191","author":[{"given":"Yuwan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lugang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailiang","family":"Miu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.biopha.2025.118514_bib1","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118514_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.biopha.2025.118514_bib3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.6004\/jnccn.2017.0100","article-title":"Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Motzer","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.biopha.2025.118514_bib4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMra1601333","article-title":"Systemic therapy for metastatic Renal-Cell carcinoma","volume":"376","author":"Choueiri","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118514_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.79.0253","article-title":"Evolving systemic treatment landscape for patients with advanced renal cell carcinoma","author":"McKay","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118514_bib6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1464-410X.2011.10629.x","article-title":"Targeted therapy for advanced renal cell cancer (RCC): a cochrane systematic review of published randomised trials","volume":"108","author":"Coppin","year":"2011","journal-title":"BJU Int."},{"issue":"9","key":"10.1016\/j.biopha.2025.118514_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrurol.2017.87","article-title":"Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach","volume":"14","author":"Siva","year":"2017","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118514_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1667\/RR14237.1","article-title":"c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines","volume":"185","author":"Gravina","year":"2016","journal-title":"Radiat. Res."},{"key":"10.1016\/j.biopha.2025.118514_bib9","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3389\/fonc.2019.01498","article-title":"N(6)-Isopentenyladenosine enhances the radiosensitivity of glioblastoma cells by inhibiting the homologous recombination repair protein RAD51 expression","volume":"9","author":"Navarra","year":"2019","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118514_bib10","doi-asserted-by":"crossref","first-page":"14277","DOI":"10.18632\/aging.203043","article-title":"Silencing UCHL3 enhances radio-sensitivity of non-small cell lung cancer cells by inhibiting DNA repair","volume":"13","author":"Liu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.biopha.2025.118514_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8060057","article-title":"Wnt signaling in renal cell carcinoma","volume":"8","author":"Xu","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118514_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13046-020-01659-y","article-title":"Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1\/beta-catenin signaling pathway in cervical cancer","volume":"39","author":"Xu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"7","key":"10.1016\/j.biopha.2025.118514_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2174\/187152009789056949","article-title":"The nitric oxide prodrug JS-K and its structural analogues as cancer therapeutic agents","volume":"9","author":"Maciag","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118514_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1227\/NEU.0b013e31823209cf","article-title":"JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas","volume":"70","author":"Weyerbrock","year":"2012","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.biopha.2025.118514_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.redox.2012.12.002","article-title":"Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance","volume":"1","author":"Maciag","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118514_bib16","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1038\/srep15104","article-title":"A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells","volume":"5","author":"Qiu","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118514_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jcp.10380","article-title":"JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways","volume":"197","author":"Ren","year":"2003","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118514_bib18","first-page":"757","article-title":"JS-K enhances chemosensitivity of prostate cancer cells to taxol via reactive oxygen species activation","volume":"17","author":"Qiu","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2025.118514_bib19","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1038\/srep15104","article-title":"A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells","volume":"5","author":"Qiu","year":"2015","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.biopha.2025.118514_bib20","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.7150\/jca.36372","article-title":"Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks","volume":"11","author":"Zhao","year":"2020","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2025.118514_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317703922","article-title":"The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation","volume":"39","author":"Heckler","year":"2017","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118514_bib22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","article-title":"Role of cell cycle in mediating sensitivity to radiotherapy","volume":"59","author":"Pawlik","year":"2004","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.biopha.2025.118514_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1158\/1541-7786.MCR-17-0205","article-title":"Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt\/beta-catenin signaling","volume":"15","author":"Emons","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118514_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013349","article-title":"WNT inhibition creates a BRCA-like state in Wnt-addicted cancer","volume":"13","author":"Kaur","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118514_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/0284186X.2014.939298","article-title":"Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review","volume":"54","author":"Kothari","year":"2015","journal-title":"Acta Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118514_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/COC.0b013e31825d52b2","article-title":"Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma","volume":"36","author":"Ranck","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118514_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","article-title":"Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma","volume":"77","author":"Wersall","year":"2005","journal-title":"Radio. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118514_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijrobp.2019.07.023","article-title":"Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer","volume":"105","author":"Zhang","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.biopha.2025.118514_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ijc.28768","article-title":"Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome","volume":"135","author":"Arai","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118514_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2008.07.038","article-title":"MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells","volume":"273","author":"Tang","year":"2009","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2025.118514_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12885-016-2775-2","article-title":"Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia","volume":"16","author":"Karim","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118514_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semradonc.2010.05.001","article-title":"Enhancing radiotherapy through a greater understanding of homologous recombination","volume":"20","author":"Barker","year":"2010","journal-title":"Semin. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118514_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013349","article-title":"WNT inhibition creates a BRCA-like state in Wnt-addicted cancer","volume":"13","author":"Kaur","year":"2021","journal-title":"EMBO Mol. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:54:39Z","timestamp":1772819679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"alternative-id":["S0753332225007085"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118514","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JS-K enhances renal cell carcinoma radiosensitivity through the Wnt\/\u03b2-catenin signaling pathway and inhibits DNA damage repair","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118514"}}